These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 39430308)

  • 1. Iontophoresis-Enhanced Buccal Delivery of Cisplatin-Encapsulated Chitosan Nanoparticles for Treating Oral Cancer in a Mouse Model.
    Chen YW; He AC; Huang TY; Lai DH; Wang YP; Liu WW; Kuo WT; Hou HH; Cheng SJ; Lee CY; Chuang WC; Chang CC; Lee BS
    Int J Nanomedicine; 2024; 19():10435-10453. PubMed ID: 39430308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan nanoparticles loading oxaliplatin as a mucoadhesive topical treatment of oral tumors: Iontophoresis further enhances drug delivery ex vivo.
    Matos BN; Pereira MN; Bravo MO; Cunha-Filho M; Saldanha-Araújo F; Gratieri T; Gelfuso GM
    Int J Biol Macromol; 2020 Jul; 154():1265-1275. PubMed ID: 31726173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipid-chitosan hybrid nanoparticles for controlled delivery of cisplatin.
    Khan MM; Madni A; Torchilin V; Filipczak N; Pan J; Tahir N; Shah H
    Drug Deliv; 2019 Dec; 26(1):765-772. PubMed ID: 31357896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice.
    Kim JH; Kim YS; Park K; Lee S; Nam HY; Min KH; Jo HG; Park JH; Choi K; Jeong SY; Park RW; Kim IS; Kim K; Kwon IC
    J Control Release; 2008 Apr; 127(1):41-9. PubMed ID: 18234388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Co-Delivery of Curcumin and Cisplatin to Enhance Cytotoxicity of Cisplatin Using Lipid-Chitosan Hybrid Nanoparticles.
    Khan MM; Madni A; Tahir N; Parveen F; Khan S; Jan N; Ali A; Abdurrahim M; Farooq U; Khan MI
    Int J Nanomedicine; 2020; 15():2207-2217. PubMed ID: 32280215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stepwise encapsulation and controlled two-stage release system for cis-Diamminediiodoplatinum.
    Chen Y; Li Q; Wu Q
    Int J Nanomedicine; 2014; 9():3175-82. PubMed ID: 25061294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microfluidic platform for synthesis and optimization of chitosan-coated magnetic nanoparticles in cisplatin delivery.
    Siavashy S; Soltani M; Ghorbani-Bidkorbeh F; Fallah N; Farnam G; Mortazavi SA; Shirazi FH; Tehrani MHH; Hamedi MH
    Carbohydr Polym; 2021 Aug; 265():118027. PubMed ID: 33966822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A cell-targeted chemotherapeutic nanomedicine strategy for oral squamous cell carcinoma therapy.
    Wang ZQ; Liu K; Huo ZJ; Li XC; Wang M; Liu P; Pang B; Wang SJ
    J Nanobiotechnology; 2015 Oct; 13():63. PubMed ID: 26427800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-encapsulation of dual drug loaded in MLNPs: Implication on sustained drug release and effectively inducing apoptosis in oral carcinoma cells.
    Mehnath S; Arjama M; Rajan M; Annamalai G; Jeyaraj M
    Biomed Pharmacother; 2018 Aug; 104():661-671. PubMed ID: 29803180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Layered nanoemulsions as mucoadhesive buccal systems for controlled delivery of oral cancer therapeutics.
    Gavin A; Pham JT; Wang D; Brownlow B; Elbayoumi TA
    Int J Nanomedicine; 2015; 10():1569-84. PubMed ID: 25759580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth of Metastatic Triple-Negative Breast Cancer Is Inhibited by Deep Tumor-Penetrating and Slow Tumor-Clearing Chemotherapy: The Case of Tumor-Adhering Liposomes with Interstitial Drug Release.
    Stras S; Howe A; Prasad A; Salerno D; Bhatavdekar O; Sofou S
    Mol Pharm; 2020 Jan; 17(1):118-131. PubMed ID: 31825626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ionically Cross-Linked Chitosan Nanoparticles for Sustained Delivery of Docetaxel: Fabrication, Post-Formulation and Acute Oral Toxicity Evaluation.
    Mahmood MA; Madni A; Rehman M; Rahim MA; Jabar A
    Int J Nanomedicine; 2019; 14():10035-10046. PubMed ID: 31908458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro cellular localization and efficient accumulation of fluorescently tagged biomaterials from monodispersed chitosan nanoparticles for elucidation of controlled release pathways for drug delivery systems.
    Hassan UA; Hussein MZ; Alitheen NB; Yahya Ariff SA; Masarudin MJ
    Int J Nanomedicine; 2018; 13():5075-5095. PubMed ID: 30233174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effect of poly lactic acid nanoparticles loaded with cisplatin and chloroquine on the oral squamous cell carcinoma.
    Li Q; Liu X; Yan W; Chen Y
    Aging (Albany NY); 2020 Dec; 13(2):2593-2603. PubMed ID: 33323546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of cisplatin-loaded chitosan nanoparticles and rituximab-linked surfaces as target-specific injectable nano-formulations for combating cancer.
    Sultan MH; Moni SS; Madkhali OA; Bakkari MA; Alshahrani S; Alqahtani SS; Alhakamy NA; Mohan S; Ghazwani M; Bukhary HA; Almoshari Y; Salawi A; Alshamrani M
    Sci Rep; 2022 Jan; 12(1):468. PubMed ID: 35013493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antitumor effects of redox-responsive nanoparticles containing platinum（Ⅳ）in ovarian cancer].
    Hou HY; Tang DS; Zhang YN; Wang KY; Ao M; Luo HX; Li B
    Zhonghua Zhong Liu Za Zhi; 2024 Jan; 46(1):76-85. PubMed ID: 38246783
    [No Abstract]   [Full Text] [Related]  

  • 18. Hydrophobic lapatinib encapsulated dextran-chitosan nanoparticles using a toxic solvent free method: fabrication, release property & in vitro anti-cancer activity.
    Mobasseri R; Karimi M; Tian L; Naderi-Manesh H; Ramakrishna S
    Mater Sci Eng C Mater Biol Appl; 2017 May; 74():413-421. PubMed ID: 28254312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonate-functionalized coordination polymer nanoparticles for the treatment of bone metastatic breast cancer.
    He Y; Huang Y; Huang Z; Jiang Y; Sun X; Shen Y; Chu W; Zhao C
    J Control Release; 2017 Oct; 264():76-88. PubMed ID: 28842315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Porphyrin-terminated nanoscale fluorescent polyrotaxane as a biodegradable drug carrier for anticancer research.
    Zhang Y; Jia S; Yuan J; Zhu P; Gan Y; Fan G; Yu S; Shi J
    Nanotechnology; 2020 Apr; 31(25):255101. PubMed ID: 32143196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.